MABTHERA Side Effects

6921988-0 | Anaemia, Blood Sodium Increased, Hypertensive Encephalopathy, Lung Infection
on Aug 02, 2010 Male patient from UNITED KINGDOM , weighting 110.2 lb, was diagnosed with prophylaxis, anaemia, seasonal allergy and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood sodium increased, hypertensive encephalopathy, lung infection. Mabthera dosage: Unk. During the same period patient was treated with MIRCERA (150 A?g, 1/month) (View Mircera Review and Mircera Label ), BACTRIM (Unk) (View Bactrim Review and Bactrim Label ), VENOFER (100 Mg, Unk) (View Venofer Review and Venofer Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ). Patient was hospitalized.

6919934-9 |
Patient was taking Mabthera (View Usage). on Aug 02, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), diabetes mellitus and. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with ACLASTA (5 Mg, Unk) (View Aclasta Review and Aclasta Label ), METHOTREXATE (10 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), NOVONORM (1 Mg, Bid) (View Novonorm Review and Novonorm Label ), DIAMICRON (30 Mg, Unk) (View Diamicron Review and Diamicron Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), XALATAN (View Xalatan Review and Xalatan Label ).

6919645-X | Arthralgia, Arthritis, Gait Disturbance, Menorrhagia
Adverse event was reported on Jul 30, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, osteopenia, gastritis and. Location: BRAZIL , weighting 125.7 lb, After Mabthera was administered, patient had the following side effects: arthralgia, arthritis (What is arthritis?), gait disturbance, menorrhagia. During the same period patient was treated with ACTEMRA (480 Mg, 1/month) (View Actemra Review and Actemra Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (2.5 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (5 Mg, 5/week) (View Folic Acid Review and Folic Acid Label ), ETORICOXIB (Unk) (View Etoricoxib Review and Etoricoxib Label ), ALENDRONIC ACID (70 Mg, 1/week) (View Alendronic Acid Review and Alendronic Acid Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ), METICORTEN (20 Mg, Unk) (View Meticorten Review and Meticorten Label ).

6912676-5 | Chest Pain, Oedema Peripheral, Urticaria
on Jul 30, 2010 Female patient from UNITED KINGDOM , weighting 88.18 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), oedema peripheral, urticaria. Mabthera dosage: Unk Mg, Unk. During the same period patient was treated with METHOTREXATE (20 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), INFLIXIMAB (Unk) (View Infliximab Review and Infliximab Label ), IRON (Unk) (View Iron Review and Iron Label ), SODIUM CHLORIDE (Unk) (View Sodium Chloride Review and Sodium Chloride Label ).


6912487-0 | Febrile Neutropenia
on Jul 26, 2010 Female patient from UNITED KINGDOM , 34 years of age, weighting 136.7 lb, was treated with Mabthera (View Usage). Patient had the following side effects: febrile neutropenia. Mabthera dosage: Unk. Patient was hospitalized.

6909419-8 | Hepatitis, Hepatitis B, Lymphopenia
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: hepatitis (What is hepatitis?), hepatitis b (What is hepatitis b?), lymphopenia on Jul 22, 2010 from BELGIUM Additional patient health information: Female patient , 65 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 1000 Mg, Q6m. During the same period patient was treated with MEDROL (Unk) (View Medrol Review and Medrol Label ). Patient was hospitalized.

6909074-7 | Dizziness, Headache, Malaise, Reversible Posterior Leukoencephalopathy Syndrome, Vomiting
Adverse event was reported on Jul 19, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1000 Unk, Unk) was diagnosed with systemic lupus erythematosus, hypertension, depression (What is depression?) and. Location: UNITED KINGDOM , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), malaise, reversible posterior leukoencephalopathy syndrome, vomiting. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Unk, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), PAROXETINE (20 Unk, Unk) (View Paroxetine Review and Paroxetine Label ), PREDNISOLONE (20 Mg, Unk) (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (20 Unk, Unk) (View Omeprazole Review and Omeprazole Label ), ASPIRIN (75 Unk, Unk) (View Aspirin Review and Aspirin Label ), METHOTREXATE (15 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

6907262-7 | Cardiac Failure, Coronary Artery Disease
on Jul 23, 2010 Female patient from UNITED KINGDOM , weighting 170.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). Patient had the following side effects: cardiac failure, coronary artery disease (What is coronary artery disease?). Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with METEX (10 Mg, Unk) (View Metex Review and Metex Label ), DECORTIN (Unk) (View Decortin Review and Decortin Label ), FOLCUR (10 Mg, Unk) (View Folcur Review and Folcur Label ), CALCIVIT (Unk) (View Calcivit Review and Calcivit Label ). Patient was hospitalized.

6906087-6 | Colitis Ulcerative
on Jul 23, 2010 Female patient from UNITED KINGDOM , 23 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: colitis ulcerative. Mabthera dosage: Unk.

6901375-1 | Hypoaesthesia, Paraesthesia, Peripheral Coldness
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, paraesthesia, peripheral coldness on Jul 23, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, weighting 194.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), hypertension, varicose vein (What is varicose vein?), chondropathy and. Mabthera dosage: 400 Mg, Q15d. During the same period patient was treated with METHOTREXATE (2.5 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), TENOXICAM (Unk) (View Tenoxicam Review and Tenoxicam Label ), ALENDRONATE SODIUM (70 Mg, 1/week) (View Alendronate Sodium Review and Alendronate Sodium Label ), ENALAPRIL (20 Mg, Qam) (View Enalapril Review and Enalapril Label ), DAFLON (500 Mg, Bid) (View Daflon Review and Daflon Label ), VIARTRIL (500 Mg, Bid) (View Viartril Review and Viartril Label ), CALCIUM/VITAMIN D (Unk) (View Calcium/vitamin D Review and Calcium/vitamin D Label ).

6901295-2 | C-reactive Protein Increased, Pneumonia
Adverse event was reported on Jul 23, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 560 Mg, Unk) was diagnosed with non-hodgkin's lymphoma, prophylaxis and. Location: UNITED KINGDOM , 82 years of age, weighting 112.4 lb, Patient had the following side effects: c-reactive protein increased, pneumonia (What is pneumonia?). During the same period patient was treated with BENDAMUSTINE (90 Mg, Unk) (View Bendamustine Review and Bendamustine Label ), ONDANSETRON (40 Mg, Unk) (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (80 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6900748-0 | Malignant Neoplasm Progression
on Jul 22, 2010 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: malignant neoplasm progression. Mabthera dosage: 1000 Mg, Unk.

6897250-1 | Hyperkalaemia, Renal Failure Acute
on Jul 21, 2010 Female patient from UNITED KINGDOM , 46 years of age, was diagnosed with diffuse large b-cell lymphoma, renal transplant and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. Mabthera dosage: Unk. During the same period patient was treated with TACROLIMUS (5 Mg, Unk) (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6897049-6 | Arthritis, Gait Disturbance
Patient was taking Mabthera (View Usage). Patient had the following side effects: arthritis (What is arthritis?), gait disturbance on Jul 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, osteopenia, gastritis and. Mabthera dosage: Unk. During the same period patient was treated with ACTEMRA (480 Mg, Unk) (View Actemra Review and Actemra Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHOTREXATE (12.5 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (5 Mg, 5/week) (View Folic Acid Review and Folic Acid Label ), ETORICOXIB (Unk) (View Etoricoxib Review and Etoricoxib Label ), ALENDRONIC ACID (70 Mg, Unk) (View Alendronic Acid Review and Alendronic Acid Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ).

6896497-8 | Pancytopenia
Adverse event was reported on Jul 22, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), myocardial ischaemia and. Location: UNITED KINGDOM , 75 years of age, After Mabthera was administered, patient had the following side effects: pancytopenia. During the same period patient was treated with ADCAL D3 (Unk) (View Adcal D3 Review and Adcal D3 Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ).

6896311-0 | Cerebrovascular Accident, Cranial Nerve Infection, Encephalitis Brain Stem, Viral Infection
on Jul 19, 2010 Female patient from GERMANY , 68 years of age, weighting 169.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis, pain (What is pain?) and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, cranial nerve infection, encephalitis brain stem, viral infection (What is viral infection?). Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with PREDNISOLON (10 Mg, Qd) (View Prednisolon Review and Prednisolon Label ), PANTOZOL (40 Mg, Qam) (View Pantozol Review and Pantozol Label ), DURAGESIC 100 (150 A?g, Q3d) (View Duragesic-100 Review and Duragesic-100 Label ), LYRICA (150 Mg, Tid) (View Lyrica Review and Lyrica Label ), DICLOFENAC (100 Mg, Qam) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6895857-9 | Cerebral Infarction
on Jul 20, 2010 Female patient from UNITED KINGDOM , 81 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient had the following side effects: cerebral infarction. Mabthera dosage: Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6888445-1 | Pancreatitis
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: pancreatitis on Jul 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 500 Mg, Unk. Patient was hospitalized.

6888408-6 | Condition Aggravated, Convulsion, Dyspnoea, Oxygen Saturation Decreased, Pulmonary Fibrosis
Adverse event was reported on Jul 20, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 1 G, Bid) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 53 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, convulsion, dyspnoea, oxygen saturation decreased, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with CARBAMAZEPINE (Unk) (View Carbamazepine Review and Carbamazepine Label ), IBUPROFEN TABLETS (Unk) (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), METHOTREXATE (22.5 G, Unk) (View Methotrexate Review and Methotrexate Label ).

6888382-2 | Pneumocystis Jiroveci Pneumonia
on Jul 19, 2010 Female patient from UNITED KINGDOM , weighting 163.1 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Mabthera dosage: 1 G, Unk. During the same period patient was treated with PREDNISOLONE (37.5 Mg, Unk) (View Prednisolone Review and Prednisolone Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), NATRILIX (Unk) (View Natrilix Review and Natrilix Label ), NOVOMIX 30 (Unk) (View Novomix 30 Review and Novomix 30 Label ), NOVORAPID (Unk) (View Novorapid Review and Novorapid Label ), STEMETIL (Unk) (View Stemetil Review and Stemetil Label ). Patient was hospitalized.

6884274-3 | Hypotension, Hypothyroidism, Thyroid Cancer
on Jul 16, 2010 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: hypotension, hypothyroidism, thyroid cancer (What is thyroid cancer?). Mabthera dosage: Unk.

6884153-1 | Dizziness, Headache, Leukoencephalopathy, Malaise, Vomiting
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), leukoencephalopathy, malaise, vomiting on Jul 19, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 136.7 lb, was diagnosed with systemic lupus erythematosus, hypertension, depression (What is depression?) and. Mabthera dosage: 1000 Unk, Unk. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Unk, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), PAROXETINE HCL (20 Unk, Unk) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), PREDNISOLONE (20 Mg, Unk) (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (20 Unk, Unk) (View Omeprazole Review and Omeprazole Label ), ASPIRIN (75 Unk, Unk) (View Aspirin Review and Aspirin Label ), METHOTREXATE (15 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

6884123-3 | Febrile Neutropenia, Lung Disorder
Adverse event was reported on Jul 12, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 675 Unk, Q21d) was diagnosed with diffuse large b-cell lymphoma and. Location: UNITED KINGDOM , weighting 158.7 lb, Patient had the following side effects: febrile neutropenia, lung disorder. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6884121-X | Confusional State, Dehydration, Dizziness, Hypokalaemia, Pyrexia
on Jul 15, 2010 Male patient from UNITED KINGDOM , 59 years of age, was diagnosed with pemphigus (What is pemphigus?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: confusional state, dehydration, dizziness (What is dizziness?), hypokalaemia, pyrexia. Mabthera dosage: 700 Mg, 1/week. Patient was hospitalized.

6883979-8 | Fatigue, Hypoaesthesia, Malaise, Malignant Melanoma, Pain In Extremity
on Jul 14, 2010 Male patient from UNITED KINGDOM , 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, hypoaesthesia, malaise, malignant melanoma, pain in extremity. Mabthera dosage: Unk.

6881332-4 | Uterine Fibrosis
Patient was taking Mabthera (View Usage). Patient had the following side effects: uterine fibrosis on Jul 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 147.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 1000 Mg, Q2w. During the same period patient was treated with METHOTREXATE (20 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6881328-2 | Anaemia, Cardio-respiratory Arrest
Adverse event was reported on Jul 15, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: 600 Mg, Q21d) was diagnosed with non-hodgkin's lymphoma, pain (What is pain?), prophylaxis and. Location: UNITED KINGDOM , 46 years of age, After Mabthera was administered, patient had the following side effects: anaemia, cardio-respiratory arrest. During the same period patient was treated with TRAMADOL HYDROCHLORIDE (Unk) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (Unk) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6880940-4 | Immunodeficiency
on Jul 13, 2010 Female patient from UNITED KINGDOM , 69 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: immunodeficiency. Mabthera dosage: Unk. During the same period patient was treated with BENDAMUSTINE (Unk) (View Bendamustine Review and Bendamustine Label ).

6880913-1 | Aortic Aneurysm Rupture
on Jul 15, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?) and was treated with Mabthera (View Usage). Patient had the following side effects: aortic aneurysm rupture. Mabthera dosage: Unk. During the same period patient was treated with ACLASTA (Unk) (View Aclasta Review and Aclasta Label ).

6876904-7 | Immune System Disorder
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: immune system disorder on Jul 13, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, was diagnosed with non-hodgkin's lymphoma and. Mabthera dosage: Unk.

6872790-X | Diabetes Mellitus, Granulocytopenia, Lung Infiltration
Adverse event was reported on Jul 12, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: 750 Unk, Q14d) was diagnosed with diffuse large b-cell lymphoma, type 2 diabetes mellitus and. Location: UNITED KINGDOM , weighting 213.8 lb, Patient experienced the following unwanted or unexpected effects: diabetes mellitus, granulocytopenia, lung infiltration. During the same period patient was treated with CYCLOPHOSPHAMIDE (1600 Unk, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (2 Unk, Unk) (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (100 Unk, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METFORMAX (500 Unk, Bid) (View Metformax Review and Metformax Label ). Patient was hospitalized.

6872788-1 | Progressive Multifocal Leukoencephalopathy
on Jul 13, 2010 Male patient from SPAIN , weighting 170.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy. Mabthera dosage: 630 Mg, Unk. During the same period patient was treated with FLUDARABINE PHOSPHATE (80 Mg, Unk) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), BENDAMUSTINE (151 Mg, Unk) (View Bendamustine Review and Bendamustine Label ), CHOP REGIMEN (Unk) (View Chop Regimen Review and Chop Regimen Label ). Patient was hospitalized and became disabled.

6872166-5 | Bladder Cancer
on Jul 12, 2010 Female patient from UNITED KINGDOM , weighting 108.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: bladder cancer (What is bladder cancer?). Mabthera dosage: 1000 Mg, Days 1+15. During the same period patient was treated with PREDNISONE (30 Mg, Unk) (View Prednisone Review and Prednisone Label ), METHYLPREDNISOLONE (100 Mg, Days 1+15) (View Methylprednisolone Review and Methylprednisolone Label ), CILAZAPRIL (Unk) (View Cilazapril Review and Cilazapril Label ), ALENDRONIC ACID (70 Mg, 1/week) (View Alendronic Acid Review and Alendronic Acid Label ), VITAMIN D3 (Unk) (View Vitamin D3 Review and Vitamin D3 Label ), AMIODARONE HCL (Unk) (View Amiodarone Hcl Review and Amiodarone Hcl Label ). Patient was hospitalized.

6872129-X | Aphasia, Cerebrovascular Accident, Confusional State, Hemiplegia, Hypoaesthesia, Progressive Multifocal Leukoencephalopathy, Status Epilepticus
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, confusional state, hemiplegia, hypoaesthesia, progressive multifocal leukoencephalopathy, status epilepticus on Feb 26, 2008 from FRANCE Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with waldenstrom's macroglobulinaemia and. Mabthera dosage: 375 Mg/m2, Unk. During the same period patient was treated with IMMUNOSUPPRESSANTS (View Immunosuppressants Review and Immunosuppressants Label ), CYCLOPHOSPHAMIDE (Unk, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6861285-5 | Haemophilus Infection, Lung Neoplasm Malignant
Adverse event was reported on Jul 09, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 132.3 lb, Patient had the following side effects: haemophilus infection, lung neoplasm malignant. During the same period patient was treated with HUMIRA (Unk) (View Humira Review and Humira Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6860981-3 | Blood Glucose Increased, Epistaxis
on Jul 08, 2010 Female patient from UNITED KINGDOM , weighting 172.0 lb, was diagnosed with thrombocytopenic purpura and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: blood glucose increased, epistaxis. Mabthera dosage: 500 Mg, Unk. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ).

6860292-6 | Cardiopulmonary Failure, Electrolyte Imbalance, Pulmonary Sepsis, Pyrexia
on Jul 07, 2010 Female patient from COLOMBIA , 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, electrolyte imbalance, pulmonary sepsis, pyrexia. Mabthera dosage: 600 Mg, Unk. Patient was hospitalized.

6850229-8 | Endometrial Cancer, Ovarian Cancer
Patient was taking Mabthera (View Usage). Patient had the following side effects: endometrial cancer, ovarian cancer on Jul 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 224.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with METHOTREXATE (15 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6848526-5 | Interstitial Lung Disease
Adverse event was reported on Jul 06, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: 800 Mg, Q21d) was diagnosed with pulmonary granuloma and. Location: UNITED KINGDOM , weighting 196.2 lb, After Mabthera was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk Unk, Q21d) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), ETOPOSIDE (Unk) (View Etoposide Review and Etoposide Label ), CARBOPLATIN (Unk) (View Carboplatin Review and Carboplatin Label ), IFOSFAMIDE (Unk) (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.

6848324-2 | Acinetobacter Infection, Dyspnoea, Hypoxia
on Jul 05, 2010 Male patient from UNITED KINGDOM , 75 years of age, weighting 130.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: acinetobacter infection, dyspnoea, hypoxia. Mabthera dosage: 375 Mg/m2, Q3w. During the same period patient was treated with CYCLOPHOSPHAMIDE (750 Mg/m2, Q3w) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (50 Mg/m2, Q3w) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (1.4 Mg/m2, Q3w) (View Vincristine Review and Vincristine Label ), PREDNISONE (40 Mg/m2, Q3w) (View Prednisone Review and Prednisone Label ).

6845479-0 | Neuropathy Peripheral
on Jul 02, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera (View Usage). Patient had the following side effects: neuropathy peripheral. Mabthera dosage: Unk. During the same period patient was treated with CHOP REGIMEN (Unk) (View Chop Regimen Review and Chop Regimen Label ).

6845292-4 | Beta Haemolytic Streptococcal Infection, Chest Discomfort, Confusional State, Pneumonia, Pyrexia, Septic Shock, Wound Drainage
Patient was taking Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: beta haemolytic streptococcal infection, chest discomfort, confusional state, pneumonia (What is pneumonia?), pyrexia, septic shock, wound drainage on Jul 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 74 years of age, weighting 180.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Mabthera dosage: 1000 Mg, Q6m. During the same period patient was treated with ALENDRONATE SODIUM (70 Mg, Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PREDNISOLONE (15 Mg, Unk) (View Prednisolone Review and Prednisolone Label ).

6844983-9 | Influenza Like Illness, Lymphocyte Count Abnormal, Non-hodgkin's Lymphoma, White Blood Cell Count Abnormal
Adverse event was reported on Jun 30, 2010 by a Male patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with b-cell lymphoma, schizophrenia and. Location: UNITED KINGDOM , 51 years of age, Patient experienced the following unwanted or unexpected effects: influenza like illness, lymphocyte count abnormal, non-hodgkin's lymphoma, white blood cell count abnormal. During the same period patient was treated with CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ), AMLODIPINE (10 Mg, Qam) (View Amlodipine Review and Amlodipine Label ), ASPIRIN (50 Mg, Qam) (View Aspirin Review and Aspirin Label ), GLICLAZIDE (Unk) (View Gliclazide Review and Gliclazide Label ), HEPSERA (Unk) (View Hepsera Review and Hepsera Label ).

6844573-8 | Blood Pressure Increased, Erysipelas, Hyperhidrosis, Petechiae, Skin Haemorrhage, Thrombosis, Weight Increased
on Jul 01, 2010 Female patient from UNITED KINGDOM , 42 years of age, weighting 249.1 lb, was diagnosed with systemic lupus erythematosus and was treated with Mabthera (View Usage). Patient had the following side effects: blood pressure increased, erysipelas, hyperhidrosis, petechiae, skin haemorrhage, thrombosis, weight increased. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with CAPTOPRIL (Unk) (View Captopril Review and Captopril Label ), FLEROXACIN (500 Mg, Unk) (View Fleroxacin Review and Fleroxacin Label ), ENALAPRIL MALEATE (20 Mg, Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), CORTISONE ACETATE (Unk) (View Cortisone Acetate Review and Cortisone Acetate Label ). Patient was hospitalized.

6841392-3 | Arrhythmia, Cough, Cyanosis, Discomfort, Dyspnoea, Erythema, Respiratory Rate Increased, Retching
on Jul 02, 2010 Female patient from UNITED KINGDOM , 38 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), cough, cyanosis, discomfort, dyspnoea, erythema, respiratory rate increased, retching. Mabthera dosage: Unk.

6840907-9 | Disease Progression, Neutropenia
Patient was taking Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, neutropenia on Jul 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, weighting 127.9 lb, was diagnosed with dermatomyositis and. Mabthera dosage: 1000 Mg, Unk. During the same period patient was treated with TEGELINE (140 G, Unk) (View Tegeline Review and Tegeline Label ), METHOTREXATE (15 Mg, Unk) (View Methotrexate Review and Methotrexate Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), DOLIPRANE (Unk) (View Doliprane Review and Doliprane Label ), CACIT D3 (1 Df, Unk) (View Cacit D3 Review and Cacit D3 Label ), SPECIAFOLDINE (10 Mg, Unk) (View Speciafoldine Review and Speciafoldine Label ), DIFFU K (600 Mg, Unk) (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6837216-0 | Abdominal Pain, Aortic Arteriosclerosis, Arthropathy, Cystitis Haemorrhagic, Gamma-glutamyltransferase Increased, Haematuria, Monocyte Count Increased, Nephrolithiasis
Adverse event was reported on Jul 05, 2010 by a Female patient taking Mabthera (View Usage) (Dosage: Unk) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 149.9 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), aortic arteriosclerosis, arthropathy, cystitis haemorrhagic, gamma-glutamyltransferase increased, haematuria, monocyte count increased, nephrolithiasis. Patient was hospitalized.

6836225-5 | Arthralgia, Erythromelalgia
on Jul 01, 2010 Female patient from UNITED KINGDOM , 47 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera (View Usage). After Mabthera was administered, patient had the following side effects: arthralgia, erythromelalgia. Mabthera dosage: Unk.

6833591-1 | Ataxia, Balance Disorder, Dizziness, Dysarthria, Fall, Gait Disturbance, Head Discomfort, Muscle Spasms
on Jul 02, 2010 Male patient from UNITED KINGDOM , weighting 176.4 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), epilepsy (What is epilepsy?) and was treated with Mabthera (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), balance disorder, dizziness (What is dizziness?), dysarthria, fall (What is fall?), gait disturbance, head discomfort, muscle spasms. Mabthera dosage: Unk. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), PRIMIDONE (View Primidone Review and Primidone Label ), METHOTREXATE (15 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6832006-7 | Lung Infection
Patient was taking Mabthera (View Usage). Patient had the following side effects: lung infection on Jul 02, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 10 years of age, was diagnosed with idiopathic thrombocytopenic purpura and. Mabthera dosage: 375 Mg/m2, 1/week. During the same period patient was treated with HORMONE (Unk) (View Hormone Review and Hormone Label ). Patient was hospitalized.